Clinical Trials List
2025-06-01 - 2028-12-31
Phase II
Recruiting6
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 王秉槐 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shu-Min Lin Division of Thoracic Medicine
- 張博瑞 Division of Thoracic Medicine
- 胡漢忠 Division of Thoracic Medicine
- 謝孟亨 Division of Thoracic Medicine
- 黃建達 Division of Thoracic Medicine
- 李忠恕 Division of Thoracic Medicine
- Kuo-Chin Kao Division of Thoracic Medicine
- 羅君禹 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 張旭良 Division of Thoracic Medicine
- 陳家閔 Division of Thoracic Medicine
- 鄭至宏 Division of Thoracic Medicine
- 莊政皓 Division of Thoracic Medicine
- jong rung Tsai Division of Thoracic Medicine
- Inn-Wen Chong Division of Thoracic Medicine
- Wei-An Chang Division of Thoracic Medicine
- Hung-Ling Huang Division of Thoracic Medicine
- 鄭孟軒 Division of Thoracic Medicine
- Ming-Ju Tsai Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林俊維 Division of Thoracic Medicine
- 紀炳銓 Division of Thoracic Medicine
- 葉金水 Division of Thoracic Medicine
- 陳正雄 Division of Thoracic Medicine
- 蔡偉宏 Division of Thoracic Medicine
- 林聖皓 Division of Thoracic Medicine
- 張時榮 Division of Thoracic Medicine
- 詹博強 Division of Thoracic Medicine
- 林明泰 Division of Thoracic Medicine
- 施穎銘 Division of Thoracic Medicine
- 黃國揚 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
252 participants
